Colin advises clients throughout their lifecycle (all the way from start-up/spin-out to multinational listed companies) on the commercialisation of their intellectual property rights. In particular, advising on licensing deals, collaborations and R&D projects, distribution and manufacturing and the IP, commercial and regulatory aspects of M&A, VC investments and IPOs.

Having a 1st class degree in Cell Biology his practice has naturally become focused on the life sciences, healthcare and technology (with a particular focus on med-tech and clean-tech) sectors.

Show full CV Hide full CV

Latest news & insights

pipette
Synapse

Private equity investment in life sciences sector

30 July 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
scientist-with-molecule-models
Life sciences & healthcare

Licensing out: Try not to get benched

27 July 2020
IN-DEPTH ANALYSIS

by Colin McCall and Justyna Ostrowska

Click here to find out more
pipette
Synapse

Arbitration for life sciences companies

29 June 2020
IN-DEPTH ANALYSIS

by multiple authors

Click here to find out more
centrifuge-machine
Synapse

Territorial licensing: "start at the end before you begin"

25 June 2020
IN-DEPTH ANALYSIS

by Colin McCall and Justyna Ostrowska

Click here to find out more

Related people

Meet me at

There are no upcoming events